Abstract
haemoglobin was used in haemodialysis patients. For sequen-ship between median haemoglobin and percentage of tial analysis, haemoglobin concentration in the first quarter patients reaching the target, shown in Figure 2 , it can of 1997 was compared to that in the last quarter. There were be estimated that to achieve the 1997 standard of 85% 1449 patients on haemodialysis and 741 on peritoneal dialysis with haemoglobin over 10.0 g/dl would require a with haemoglobin data available. Anonymity of the centres median haemoglobin of 11.5 g/dl.
is an important principle of the Registry. Whilst the number of participating centres is small, identification of the centre by the number of patients they dialyse is possible and Effect of age, change of dialysis modality, gender, and therefore results for individual centres are reported as per-duration of renal replacement therapy centages. The number of patients in each centre ranged from 63 to 256 for haemodialysis patients and 29 to 226 for Change of dialysis modality was associated with reducperitoneal dialysis. tion in haemoglobin, justifying the exclusion from the The data collected were haemoglobin concentration, serum rest of the analysis of patients who had not been stable ferritin, and pre-and post-haemodialysis urea concentrations on a mode of dialysis for more than 3 months. Change to allow calculation of urea reduction ratio as a measure of from peritoneal dialysis to haemodialysis was associdelivered dialysis dose. The technique for post-dialysis urea ated with a 1.7 g/dl reduction in mean haemoglobin sampling was not standardized between centres. Age, gender, (95% CI 1.0-2.5, P<0.0001). Change from haemodiaduration of renal replacement therapy, and the prescription lysis to peritoneal dialysis was associated with a 1.2 g/dl of erythropoietin were recorded. reduction in mean haemoglobin (95% CI 0.6-1.9, P=0.0002).
Statistical analysis
A statistically significant correlation between age and haemoglobin concentration was found in periton- given. In the assessment of the significance of age and linear trend was found between erythropoietin preduration of renal replacement therapy on haemoglobin con-scription and age. Men had significantly higher haemocentration, Spearman's correlation was used since it detects globin concentrations than women on both any increasing or decreasing relationship rather than spe-haemodialysis and peritoneal dialysis ( Table 3 ). There cifically linear relationships. The effect of gender was com-was no evidence to suggest underprescribing of erythropared using two sample t-tests. The cumulative frequency poietin in women compared to men, as overall more distribution graphs were smoothed using a cubic spline females were on erythropoietin than males. There was graphy between units, analysis of variance was used to calculate the mean haemoglobin adjusted for age, gender, Statistically significant but weak correlations were and length of time on treatment, and also polycystic kidney found between haemoglobin and length of time on disease, which is known to be associated with higher renal replacement therapy (haemodialysis: r s 0.14, haemoglobin.
P<0.0001; peritoneal dialysis: r s −0.11, P=0.004). The proportion of patients requiring erythropoietin therapy increased with time on renal replacement treat- Table 2 shows that a higher proportion of peritoneal dialysis patients with haemoglobin less haemoglobin for haemodialysis patients, although the 95% confidence interval for centres D and I crossed than 10.0 g/dl are not on erythropoietin compared with haemodialysis patients, indicating a relative reluctthe standard level. Data from centre I should be viewed with caution as the proportion of patient data returned ance to prescribe erythropoietin to peritoneal dialysis patients. The dose of erythropoietin prescription was was lower than from other centres. Three centres reached the standard for peritoneal dialysis patients not available to the Renal Registry.
Results

ment (
As expected, diagnosis affected achieved haemo-( Table 2 ). In each of these the 95% confidence interval crossed below the standard level. In an additional four globin, and patients with polycystic kidney disease had higher haemoglobin than patients with other diagnoses centres, whilst the median was below the standard, the 95% confidence interval crossed above it.
(difference in haemodialysis, 1.0 g/dl, 95% CI 0.7-1.4 g/dl, P<0.0001; difference in peritoneal diaThe distribution of haemoglobin concentrations for patients on haemodialysis and peritoneal dialysis are lysis, 0.9 g/dl, 95% CI 0.5-1.4 g/dl, P<0.0001). To investigate whether differences in age, gender, duration shown in Figure 1 . The shape of the distribution of haemoglobin concentrations was similar regardless of of treatment, or polycystic kidney disease could explain the differences in mean haemoglobin achieved at the the median haemoglobin achieved. From the relation- centres, the means were adjusted for these variables factors (for example finance) influence erythropoietin prescription and this is therefore difficult to interpret. using analysis of variance. There was little difference between the adjusted and unadjusted means and these The small numbers and broad confidence intervals mean that statistically valid comparison is difficult, but variables are unlikely to explain the observed differences between centres.
individual centres may wish to use the information in Tables 1 and 2 to compare their practice with others. For instance, haemodialysis patients in centre B have Effect of serum ferritin, erythropoietin prescription, and good iron stores, excellent urea reduction ratios, and dialysis quality on haemoglobin high proportion of patients not requiring erythropoieErythropoietin prescription, iron stores, and dialysis tin, but a low attainment of the target haemoglobin, quality are thought to influence haemoglobin. The likely to be due to a low level of erythropoietin proportion of patients who do not require erythropoie-prescribing. Centre D achieved the highest median tin treatment to maintain a haemoglobin greater than haemoglobin in haemodialysis patients despite only 10.0 g/dl may be a useful indicator of whether the average achievement of all the other measures. The overall management within a centre is conducive to attainment of the target was higher in centre D than high or low haemoglobin. Figure 3a shows that there in centre F, although the other measures were virtually may he a relationship between achievement of urea identical in the two centres, demonstrating that these reduction ratio of greater than 65% and the proportion measured variables cannot entirely explain achieved of patients with haemoglobin concentration spontan-haemoglobin. Similar analyses can be made for peritoneously greater than 10.0 g/dl. However, given the small eal dialysis, although the data set is less complete. number of centres with adequate data, formal statistical analysis has not been performed. Similarly, Changes in haemoglobin with time Figure 3b shows that the proportion of patients on erythropoietin may be inversely related to the propor-Sequential data were only available for 1 year and analysis of changes over time was limited. Differences tion with good urea clearance, although many other (a) (b) Fig. 1 . Frequency distribution plots of haemoglobin for (a) haemodialysis patients and (b) peritoneal dialysis patients in nine UK renal centres. The curves for each centre were smoothed using a cubic spline algorithm.
in attainment of the haemoglobin standard between Peritoneal dialysis patients started the year with higher haemoglobins than haemodialysis patients but in sevthe first and last quarters of 1997 are shown in Figure 4 . For haemodialysis, only one centre did not increase eral centres attainment of the standard declined through the year. the proportion of patients achieving the standard. selves as governed by local issues such as finance but this information is not available to the registry.
The registry data show that changes of dialysis modality from haemodialysis to peritoneal dialysis or vice versa were associated with a fall in haemoglobin. This might be expected for a change to haemodialysis but is more surprising for a change to peritoneal dialysis. Since change of modality is most often precipitated by a problem with the dialysis or an intercurrent illness, it is likely that the underlying problem is the cause of a fall in haemoglobin rather than its being due solely to the change of dialysis technique.
The proportion of patients achieving the target haemoglobin varied widely between centres. Of the Fig. 2 . Relationship between median haemoglobin and percentage demographic factors examined, only gender and diaof patients with haemoglobin above 10 g/dl in each centre; 2 gnosis of polycystic kidney disease had a clinically haemodialysis, $ peritoneal dialysis. . significant effect on haemoglobin concentration. The proportion of patients with ferritin levels over 100 ng/ml varied widely between units. The Renal
Discussion
Association has not set a standard for intravenous iron use. The UK Renal Association has set desirable standards
In the normal population, females have lower haefor attainment of a target haemoglobin (10.0 g/dl ). moglobin than males, probably due to androgen proEuropean Best Practice Guidelines for the management duction by males. This difference is maintained in the of anaemia in patients with chronic renal failure have dialysis population, despite no gender difference in the recently been published suggesting a target haemostated target haemoglobin. A higher proportion of globin concentration of 11.0 g/dl [18] . In 1995 the females than males was treated with erythropoietin. Renal Association set 80% achievement of the target Since females naturally have a lower haemoglobin, it haemoglobin as the standard, this was increased to is possible that the difference in proportion treated 85% in 1997. The European guidelines also suggest a with erythropoietin should be even greater. To ensure minimum standard of 85% achievement of their higher that there was no discrimination against females in target. Despite the setting of these standards, the erythropoietin prescribing we examined those with benchmark proportion of a dialysis population that haemoglobin less than 10.0 g/dl. For both males and could reasonably be expected to achieve the targets by females, these patients would be expected to be prebest practice is not known.
scribed erythropoietin in an attempt to achieve the There are some patients, for example those with target. Amongst this group, there was no significant homozygous sickle-cell anaemia [19] , for whom a difference between males and females, demonstrating haemoglobin over 10.0 g/dl is deleterious. High haemono evidence of underprescribing of erythropoietin to globin concentration might also increase the risk of females. Whether the optimum haemoglobin for males vascular access thrombosis and cardiovascular events.
and females is the same is unknown. Since there is no Intercurrent illness and erythropoietin resistance mean difference in the target haemoglobin for males and that some patients will inevitably fall below the target.
females it should be recognized that it may be more It is not known how long it can be expected to take difficult to reach the standard in females. for a new uraemic patient to reach the target haemoAdjustment for differences in age, gender, duration globin once treatment has been started. It is possible that individual centres set different targets for them-of dialysis and diagnoses between centres did not level than achieved for haemodialysis patients. The relative underprescribing of erythropoietin to peritoneal dialysis patients may be because they are mainly noticeably alter the variability in mean haemoglobin, treated at home and usually have to administer their which is therefore likely to be due to differences in own erythropoietin, whereas haemodialysis patients aspects of management. Differences between centres more often attend centres where erythropoietin can be were not tested statistically because numbers in each given to them. Underprescribing to peritoneal dialysis centre are small whilst the number of possible compar-patients suggests that it should be possible to improve isons is large. Nevertheless, individual centres will find their haemoglobin further. comparison with others useful in assessing their own With current practice the shape of the distribution practice. In every centre, it was possible to identify of haemoglobin concentrations was similar regardless changes in management that might increase haemo-of median haemoglobin. The data suggests that to globin levels. Unfortunately, reliable data on erythro-achieve the target of 85% of patients with haemoglobin over 10.0 g/dl requires a median for the population of poietin prescribing is difficult to achieve, as the incidence, prognosis and risk factors. Kidney Int 1995; 47: around 11.5 g/dl. This implies a significant proportion [884] [885] [886] [887] [888] [889] [890] of patients with a haemoglobin concentration above 
